Radiation doses for identical CT scans are still variable, despite lower levels overall.
Computed tomography (CT) scan radiation doses are dropping, but they remain variable even for identical examinations, according to a study published in the American Journal of Roentgenology. Researchers from the United States and Switzerland sought to determine the radiation doses used among adult patients undergoing clinically indicated, repeat identical thoracoabdominal CT examinations. The researchers obtained radiation dose data from 2,851 subjects who underwent 12,635 repeat identical CT scans in one health system. There were a mean of 4.8 scans per patient. The CT protocols included in the study were: • Chest-abdomen-pelvis with contrast administration (4,621 CT studies of 1,064 patients); Abdomen-pelvis with contrast administration (876 CT studies of 261 patients);• Renal stone (1,053 CT studies of 380 patients); and • Chest without contrast (6,085 CT studies of 1,146 patients). The results showed a trend was observed toward global reduction in size-specific dose estimate (SSDE) values with all protocols investigated: • Chest-abdomen-pelvis slope, −1.78; • Abdomen-pelvis slope, −0.82; • Renal stone slope, −0.83; and• Chest slope, −0.47. The intraindividual analyses of radiation dose distribution showed widespread variability in SSDE values across the four protocols investigated: • Chest-abdomen-pelvis mean coefficient of variance, 14.02 mGy; • Abdomen-pelvis mean coefficient of variance, 10.26 mGy; • Renal stone mean coefficient of variance, 34.18 mGy; and• Chest mean coefficient of variance, 6.74 mGy. “Although there is a trend toward global reduction in radiation doses, this study showed widespread variability in the radiation dose that each patient undergoing identical repeat thoracoabdominal CT protocols absorbs,” the authors concluded. “These data may provide a foundation for the future development of best-practice guidelines for patient-specific radiation dose monitoring.”
What is the Best Use of AI in CT Lung Cancer Screening?
April 18th 2025In comparison to radiologist assessment, the use of AI to pre-screen patients with low-dose CT lung cancer screening provided a 12 percent reduction in mean interpretation time with a slight increase in specificity and a slight decrease in the recall rate, according to new research.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
Can CT-Based AI Radiomics Enhance Prediction of Recurrence-Free Survival for Non-Metastatic ccRCC?
April 14th 2025In comparison to a model based on clinicopathological risk factors, a CT radiomics-based machine learning model offered greater than a 10 percent higher AUC for predicting five-year recurrence-free survival in patients with non-metastatic clear cell renal cell carcinoma (ccRCC).
Could Lymph Node Distribution Patterns on CT Improve Staging for Colon Cancer?
April 11th 2025For patients with microsatellite instability-high colon cancer, distribution-based clinical lymph node staging (dCN) with computed tomography (CT) offered nearly double the accuracy rate of clinical lymph node staging in a recent study.